Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.490
-0.060 (-2.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $123.41 million as of December 20, 2024. Its market cap has decreased by -42.98% in one year.
Market Cap
123.41M
Enterprise Value
169.04M
1-Year Change
-42.98%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $123.41M, a decrease of -82.71%. That is a compound annual growth rate of -37.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 123.41M | -48.47% |
| Dec 29, 2023 | 239.49M | -34.07% |
| Dec 30, 2022 | 363.24M | -36.24% |
| Dec 31, 2021 | 569.65M | -20.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 129.60M |
| Achieve Life Sciences | 126.90M |
| Black Diamond Therapeutics | 125.62M |
| TriSalus Life Sciences | 123.50M |
| Lineage Cell Therapeutics | 122.99M |
| Zomedica | 122.79M |
| Atossa Therapeutics | 121.23M |
| American Well | 120.57M |